Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon
BMS Not Yet Recruiting Study icon

Not Yet Recruiting

Trial ID CN012-0066  |   NCT07101094

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Warning icon
Sorry, this study is not yet accepting participants.
Please bookmark this page to check back at a later date.  You may also click the “Check Your Eligibility” button and answer a few questions about your health to find out if you might be a match to another study.

Summary

  • Male and Female Gender icon
  • 18+
    Age Range
  • 7
    Locations
  • BMS Not Yet Recruiting Study icon
    Not Yet Recruiting

Overview

The purpose of this study is to understand treatment preference and satisfaction among adults with schizophrenia in the United States who are prescribed xanomeline and trospium chloride (X/T) therapy

Key Eligibility Criteria

Inclusion Criteria

Inclusion Criteria Icon img
:
  • Aged ≥18 years at index date.
    1. Have a confirmed diagnosis of schizophrenia before index date.
      1. Receipt of an initial prescription order for xanomeline and trospium chloride (XT) and plan to fill and initiate such therapy.
        1. Provide a signed and dated Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent form (ICF) in accordance with regulatory, local, and institutional guidelines.
          1. Agree to use an electronic device to record, or provide paper entry of, patient-reported outcomes (in English or Spanish).
            1. English or Spanish speaking.

              Exclusion Criteria

              Exclusion Criteria Icon
              :
              • Participation in an interventional study within the last 30 days or plan to participate in such study at the time of eligibility screening.
                1. Evidence of use of XT prior to time of eligibility screening.
                  Additional Information *

                  Treatment Options

                  Study Arms

                  ASSIGNED INTERVENTION

                  Study Arms

                  Participants receiving xanomeline and trospium chloride (X/T) therapy

                  ASSIGNED INTERVENTION
                  • Drug: xanomeline and trospium chloride (X/T) therapy
                  Please check back later for a recruiting site or find another trial by clicking 'Check Your Eligibility'
                  Check Your Eligibility
                  Answer some questions about Your health to see if you may match to this trial
                  Match to a Trial
                  If you are a match, click on the study to see the list of study site locations.
                  Select a Study Site Location
                  Select a study site location that is convenient for you
                  Register
                  Provide your contact details for the study site to connect with you.

                  Help us enhance your website experience! Share your feedback with our team at BMS Clinical Trials to improve yours and others’ experience. Thank you

                  Help us enhance your website experience! Share your feedback with our team at BMS Clinical Trials to improve yours and others’ experience. Thank you